Lebwohl, M.G., Sugarman, J., Pariser, D.M., Bagel, J., Trickett, C., Jacobson, A. and Israel, R. 2020. Safety and Tolerability of Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% (HP/TAZ) Lotion in Patients With Moderate-to-Severe Plaque Psoriasis: Results From a 1-Year, Open-Label Study. SKIN The Journal of Cutaneous Medicine. 4, 5 (Sep. 2020), s38. DOI:https://doi.org/10.25251/skin.4.supp.38.